Epimedix Inc entered the industry of Noncommercial Research Organizations in 0 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 541720, which describes it as a Noncommercial Research Organizations. For further clarification, the SIC classifies this business under the code 8733 and described it as a Noncommercial Research Organizations. The business provides service to the B2B market.
To acquire more information, please contact Jeff Perlman by calling (202) 547-9180 during business hours. You can also write to the business’ Branch at 700 East St Se, Washington, District of Columbia DC 20003. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Epimedix Inc |
| Representative: | Jeff Perlman |
| Place of Business: | 700 East St Se, Washington, DC 20003 |
| Contact Number: | (202) 547-9180 |
| Type of Service: | Noncommercial Research Organizations |
| SIC Number: | 8733 |
| NAICS Number: | 541720 |
| Locality: | Branch |
| Market Type: | B2B (Business to Business) |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Epimedix Inc is a company operating from District of Columbia, District of Columbia providing professional Noncommercial Research Organizations and relevant B2B variables. It was founded in 0 and registered with the SIC code 8733 as Noncommercial Research Organizations, and with the NAICS code 541720 as Noncommercial Research Organizations.
With a current employee count of 1 to 4, Epimedix Inc has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Jeff Perlman at (202) 547-9180 for related queries, or to locate its Branch using the coordinates 38.882854,-76.99598.
The Branch can also be found at the street address 700 East St Se in Washington, District of Columbia 20003 and can be engaged online through the company website at , the company Twitter , and Facebook page .